Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Jun;210(6):422-428.
doi: 10.1192/bjp.bp.116.189134. Epub 2017 Mar 2.

Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial

Affiliations
Randomized Controlled Trial

Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial

Gordon Fernie et al. Br J Psychiatry. 2017 Jun.

Erratum in

Abstract

BackgroundKetamine has recently become an agent of interest as an acute treatment for severe depression and as the anaesthetic for electroconvulsive therapy (ECT). Subanaesthetic doses result in an acute reduction in depression severity while evidence is equivocal for this antidepressant effect with anaesthetic or adjuvant doses. Recent systematic reviews call for high-quality evidence from further randomised controlled trials (RCTs).AimsTo establish if ketamine as the anaesthetic for ECT results in fewer ECT treatments, improvements in depression severity ratings and less memory impairment than the standard anaesthetic.MethodDouble-blind, parallel-design, RCT of intravenous ketamine (up to 2 mg/kg) with an active comparator, intravenous propofol (up to 2.5 mg/kg), as the anaesthetic for ECT in patients receiving ECT for major depression on an informal basis. (Trial registration: European Clinical Trials Database (EudraCT): 2011-000396-14 and clinicalTrials.gov: NCT01306760)ResultsNo significant differences were found on any outcome measure during, at the end of or 1 month following the ECT course.ConclusionsKetamine as an anaesthetic does not enhance the efficacy of ECT.

PubMed Disclaimer

Conflict of interest statement

Declaration of interestC.AS. reports grants from Vifor Pharma, outside the submitted work. I.C.R. (deceased) declared personal fees from AstraZeneca, Sanofi Aventis and Sunovion, and non-financial support from Lundbeck, between 2009 and 2014 and all outside the submitted work.

Figures

Fig. 1
Fig. 1
CONSORT flow diagram showing patient eligibility and inclusion in the trial. *One patient is the same patient; Patient refused Cambridge Automated Neuropsychological Test Battery Spatial Recognition Memory task (CANTAB SRM) (n = 1); Completed over telephone so no CANTAB (n = 1). ECT, electroconvulsive therapy.
Fig. 2
Fig. 2
Mean scores on the dependent measures across time (pre-electroconvulsive therapy (ECT), post-final ECT and 1-month post-ECT) by anaesthetic group (treatment effects analysis). (a) Group differences in Hamilton Rating Scale for Depression (HRSD) ratings across follow-up, (b) group differences in Montgomery–Åsberg Depression Rating Scale (MADRS) ratings across follow-up, (c) group differences in Cambridge Automated Neuropsychological Test Battery Spatial Recognition Memory task (CANTAB SRM) scores across follow-up. Error bars are the standard error of the mean.

References

    1. World Health Organization Depression Fact sheet N369. WHO, 2015. (http://www.who.int/mediacentre/factsheets/fs369/en/).
    1. Waite J, Easton A. The ECT Handbook (3rd edn). Royal College of Psychiatrists, 2013.
    1. Zarate CA, Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63: 856–64. - PubMed
    1. Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry 2013; 170: 1134–42. - PMC - PubMed
    1. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000; 47: 351–4. - PubMed

Publication types

Associated data